No ownership or control links for LI ZHILIN are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is LI ZHILIN's risk level?

WhiteIntel flags LI ZHILIN as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does LI ZHILIN appear across sources?

LI ZHILIN is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

Dossier

■

LI ZHILIN

Name: LI ZHILIN — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, LI ZHILIN, Company, US

Low

CompanyUS

View network JSON / MCPsample

Fig. 01 — Cross-source signature

/01

At a glance

Dimensions on file

Subsidiaries: 3

/02

Key facts

Risk signal

Low

Risk

LI ZHILIN is a Company registered in US resolved across 1 source in the WhiteIntel corporate-ownership graph.

/03

Ownership & control

Owners / controllers

None in current sources.

Holdings / subsidiaries

LI ZHILIN
- CHINA PHARMA HOLDINGS, INC.· director· via SEC EDGAR

/04

Directorship network

8 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

CHINA PHARMA HOLDINGS, INC.

LIU TAO (CHENGDU)tenpercentowner
DENG KEtenpercentowner
WAUNG FRANKofficer
TSUI HEUNG MEIdirector
TSUI HEUNG MEItenpercentowner
ZHANG YINGWENdirector
DONG BAOWENdirector
BENNETT G MICHAELdirector

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on LI ZHILIN. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnakeScore.

Loading tips…